Cite
HARVARD Citation
Tsuji, M. et al. (2017). Sequential Use of Second-Generation Tyrosine Kinase Inhibitor Treatment and Intensive Chemotherapy Induced Long-Term Complete Molecular Response in Imatinib-Resistant CML Patient Presenting as a Myeloid Blast Crisis. Case reports in hematology. p. . [Online].